SCHEMBL627226

SCHEMBL627226

CC(C)(C)OC(=O)NC1CCN(c2nn3cc(I)nc3s2)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.46
SKP1 P63208 1/20 0.46
SKP2 Q13309 1/20 0.46
CTSK P43235 2/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
SUV39H2 Q9H5I1 7/20 0.41
BTK Q06187 2/20 0.40
JAK3 P52333 1/20 0.40
MAPT P10636 2/20 0.40
KCNA3 P22001 1/20 0.40
PDE10A Q9Y233 1/20 0.39
RET P07949 1/20 0.39
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627193 0.94 BTK (0.46) CKS1BSKP1SKP2CTSKSUV39H2
SCHEMBL628264 0.89 BTK (0.51) CTSKBTKJAK3MAPTPDE10A
SCHEMBL626887 0.85 CKS1B (0.48) CKS1BSKP1SKP2SUV39H2MAPT
SCHEMBL626399 0.82 KDM1A (0.38) CKS1BSKP1SKP2CTSKBTK
SCHEMBL627265 0.79 CKS1B (0.41) CKS1BSKP1SKP2MAPTMAP4K4
SCHEMBL627225 0.79 CKS1B (0.48) CKS1BSKP1SKP2CTSKOPRM1
SCHEMBL626211 0.79 IRAK1 (0.48) CKS1BSKP1SKP2SUV39H2MAPT
SCHEMBL625132 0.76 CKS1B (0.42) CKS1BSKP1SKP2MAPTRET
SCHEMBL628000 0.76 MAPT (0.42) MAPT
SCHEMBL628407 0.75 CYP11B2 (0.44) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed